The role of tyrosine hydroxylase gene variants in suicide attempt in schizophrenia

Neuroscience Letters

Volumn 559, Issue , 2014, Pages 39-43

  Hu, Jiayi ^a   Chan, Lai Fong ^a,b   Souza, Renan P ^a   Tampakeras, Maria ^a   Kennedy, James L ^a   Zai, Clement ^a   De Luca, Vincenzo ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Clinical risk factors; Schizophrenia; Suicide attempt; Tyrosine hydroxylase gene

Indexed keywords

ALCOHOL; ILLICIT DRUG; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DSM-IV; ETHNICITY; FEMALE; HAPLOTYPE; HEAD INJURY; HUMAN; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANCE ABUSE; SUICIDE ATTEMPT;

CLINICAL RISK FACTORS; SCHIZOPHRENIA; SUICIDE ATTEMPT; TYROSINE HYDROXYLASE GENE;

ADULT; FEMALE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUICIDE, ATTEMPTED; TYROSINE 3-MONOOXYGENASE;

EID: 84890290218     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.11.025     Document Type: Article

References (22)

1. Barrett E.A., Sundet K., Faerden A., Nesvåg R., Agartz I., Fosse R., Mork E., Steen N.E., Andreassen O.A., Melle I. Suicidality before and in the early phases of first episode psychosis. Schizophr. Res. 2010, 119(1-3):11-17.
2. Bushe C., Taylor M., Haukka J. Mortality in schizophrenia - a measurable clinical endpoint. J. Psychopharmacol. 2010, 24(S4):17-25.
3. Carlborg A., Winnerbäck K., Jönsson E.G., Jokinen J., Nordström P. Suicide in schizophrenia. Expert Rev. Neurother. 2010, 10(7):1153-1164.
4. T.I.H.Consortium The international HapMap project. Nature 2003, 426:789-796.
5. Cross-Disorder Group of the Psychiatric Genomics Consortium, Smoller J.W., Craddock N., Kendler K., Lee P.H., Neale B.M., Nurnberger J.I., Ripke S., Santangelo S., Sullivan P.F. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381(9875):1371-1379.
6. Dumais A., Lesage A.D., Alda M., Rouleau G., Dumont M., Chawky N., Roy M., Mann J.J., Benkelfat C., Turecki G. Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am. J. Psychiatry 2005, 162(11):2116-2124.
7. De Luca V., Strauss J., Kennedy J.L. Power based association analysis (PBAT) of serotonergic and noradrenergic polymorphisms in bipolar patients with suicidal behavior. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(1):197-203.
8. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CV) 1997, American Psychiatric Association, Washington.
9. Gos T., Krell D., Bielau H., Brisch R., Trübner K., Steiner J., Bernstein H.G., Jankowski Z., Bogerts B. Tyrosine hydroxylase immunoreactivity in the locus coeruleus is elevated in violent suicidal depressive patients. Eur. Arch. Psychiatry Clin. Neurosci. 2008, 258:513-520.
10. Giegling I., Moreno-De-Luca D., Calati R., Hartmann A.M., Möller H.J., De Ronchi D., Rujescu D., Serretti A. Tyrosine hydroxylase and DOPA decarboxylase gene variants in personality traits. Neuropsychobiology 2009, 59(1):23-27.
11. Hor K., Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. J. Psychopharmacol. 2010, 24(S4):81-90.
12. Hubisz M.J., Fal D. Inferring weak population structure with the assistance of sample group information. Mol. Ecol. Resour. 2009, 9(5):1322-1332.
13. Lahiri D.K., Nurnberger J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991, 19(19):5444.
14. Jönsson E., Sedvall G., Brené S., Gustavsson J.P., Geijer T., Terenius L., Crocq M.A., Lannfelt L., Tylec A., Sokoloff P., Schwartz J.C., Wiesel F.A. Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biol. Psychiatry 1996, 40(10):1032-1043.
15. Levine S.Z., Bakst S., Rabinowitz J. Suicide attempts at the time of first admission and during early course schizophrenia: a population based study. Psychiatry Res. 2010, 177(1-2):55-59.
16. Persson M.L., Wasserman D., Geijer T., Jönsson E.G., Terenius L. Tyrosine hydroxylase allelic distribution in suicide attempters. Psychiatry Res. 1997, 72(2):73-80.
17. Pompili M., Amador X.F., Girardi P., Harkavy-Friedman J., Harrow M., Kaplan K., Krausz M., Lester D., Meltzer H.Y., Modestin J., Montross L.P., Mortensen P.B., Munk-Jørgensen P., Nielsen J., Nordentoft M., Saarinen P.I., Zisook S., Wilson S.T., Tatarelli R. Suicide risk in schizophrenia: learning from the past to change the future. Ann. Gen. Psychiatry 2007, 6(10). 10.1186/1744-859X-6-10.
18. Ran M.S., Xiang M.Z., Mao W.J., Hou Z.J., Tang M.N., Chen E.Y.H., Chan C.L.W., Yip P.S.F., Conwell Y. Characteristics of suicide attempters and nonattempters with schizophrenia in a rural community. Suicide Life Threat. Behav. 2005, 35:694-701.
19. Sinnwell J.P., Schaid D.J. haplo.stats: statistical analysis of haplotypes with traits and covariates when linkage phase is ambiguous. R package version 1.2.2. 2005.
20. Souery D., Oswald P., Linkowski P., Mendlewicz J. Molecular genetics in the analysis of suicide. Ann. Med. 2003, 35(3):191-196.
21. Uzun O., Tamam L., Ozcüler T., Doruk A., Unal M. Specific characteristics of suicide attempts in patients with schizophrenia in Turkey. Isr. J. Psychiatry Relat. Sci. 2009, 46(3):189-194.
22. Wasserman D., Rihmer Z., Rujescu D., Sarchiapone M., Sokolowski M., Titelman D., Zalsman G., Zemishlany Z., Carli V., European Psychiatric Association The European Psychiatric Association (EPA) guidance on suicide treatment and prevention. Eur. Psychiatry 2012, 27(2):129-141.